Evidence map›Paper›PMID 32868781›Full record

ArticleNature communications2020

Cardiac dopamine D1 receptor triggers ventricular arrhythmia in chronic heart failure.

Toshihiro Yamaguchi, Tomokazu S Sumida, Seitaro Nomura, Masahiro Satoh, Tomoaki Higo, Masamichi Ito, Toshiyuki Ko, Kanna Fujita, Mary E Sweet, Atsushi Sanbe and 8 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
6.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 80 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Clozapine acts as an antagonist of human dopamine DNaunyn-Schmiedeberg's archives of pharmacology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. 4,4'-DMARFrontiers in cardiovascular medicine · 2026
    Article
  15. Article
  16. Review
  17. Temperature alters the inotropic and chronotropic effect of DNaunyn-Schmiedeberg's archives of pharmacology · 2025
    Article
  18. Article
  19. Article
  20. Dopamine receptors and organ fibrosis.Biochemistry and biophysics reports · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 9 institutions in 2 countries.

Toshihiro Yamaguchi *Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Tomokazu S Sumida *Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0002-9806-2642
Seitaro NomuraDepartment of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Masahiro SatohGenome Science Division, Research Center for Advanced Science and Technologies, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0002-8770-7302
Tomoaki HigoDepartment of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Masamichi ItoDepartment of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Toshiyuki KoDepartment of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Kanna FujitaDepartment of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Mary E SweetHuman Medical Genetics and Genomics, University of Colorado, Boulder, CO, USA.
Atsushi SanbeDepartment of Pharmacotherapeutics, School of Pharmacy, Iwate Medical University, Morioka, Japan.
Kenji YoshimiDepartment of Neurophysiology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Ichiro ManabeDepartment of Disease Biology and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
Toshikuni SasaokaDepartment of Comparative and Experimental Medicine, Brain Research Institute, Niigata University, Niigata, Japan.
Matthew R G TaylorHuman Medical Genetics and Genomics, University of Colorado, Boulder, CO, USA.
Haruhiro TokoDepartment of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Eiki TakimotoDepartment of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Atsuhiko T NaitoDepartment of Physiology, Faculty of Medicine, Toho University, Tokyo, Japan. atsuhiko.naito@med.toho-u.ac.jp.ORCID http://orcid.org/0000-0003-2534-1920
Issei KomuroDepartment of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. komuro-tky@umin.ac.jp.
The University of Tokyo · JPChiba University · JPUniversity of Colorado Boulder · USIwate Medical University · JPJuntendo University · JPNiigata University · JPThe University of Osaka · JPToho University · JPYale University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pathophysiological roles of cardiac dopamine system remain unknown. Here, we show the role of dopamine D1 receptor (D1R)-expressing cardiomyocytes (CMs) in triggering heart failure-associated ventricular arrhythmia. Comprehensive single-cell resolution analysis identifies the presence of D1R-expressing CMs in both heart failure model mice and in heart failure patients with sustained ventricular tachycardia. Overexpression of D1R in CMs disturbs normal calcium handling while CM-specific deletion of D1R ameliorates heart failure-associated ventricular arrhythmia. Thus, cardiac D1R has the potential to become a therapeutic target for preventing heart failure-associated ventricular arrhythmia.

Indexed as

Heart FailureAnimalsArrhythmias, CardiacGene Expression ProfilingHumansMiceMice, TransgenicMyocytes, CardiacRatsReceptors, Dopamine D1Sequence Analysis, RNASingle-Cell AnalysisTachycardia, VentricularDRD1 protein, humanReceptors, Dopamine D1

Identifiers

PMID32868781
PMCPMC7459304
OpenAlexW3081868006

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.